Cancellation of Non-Binding MOU for Investment in OCON Medical – Negotiations for a New MOU Underway Post published:15/12/2024
E.F.A (5.28%) is in a non-binding memorandum of understanding with a third party for an investment in the range of $4 million to $5 million Post published:27/10/2024
FDA approval received for CardiaXense’s medical wristwatch for heart rate monitoring (5% stake held) Post published:06/05/2024
E.F.A (Portfolio Company) completed an investment round totaling approximately $3 million, and the conversion of SAFE investments holds a stake of 4.4% Post published:06/03/2024
